Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Proline and glutamate rich with coiled coil domain protein 1 (PERCC1)** is a transcriptional co-regulator and a newly recognized member of the YAP/TAZ/FAM181 family, containing conserved TEAD-interacting motifs[1]. It is expressed at very low levels in a limited range of tissues, with highest expression in enteroendocrine cells, especially **gastric G cells** and duodenal enteroendocrine cells. PERCC1 plays a critical developmental role in the gastrointestinal tract by promoting the generation and function of enteroendocrine cells required for normal digestive physiology[1][3][4]. Loss of function causes a congenital diarrheal syndrome in humans and mice, due to failure of specific populations of gut endocrine cells to develop, resulting in nutrient malabsorption and failure to thrive[2]. Its precise molecular mechanism involves interaction with TEAD transcription factors—similar to YAP and TAZ—but unlike these canonical targets, PERCC1 currently has no known established interaction with small-molecule drugs and is not a validated therapeutic target[1][2][3][4]. No evidence currently supports a role in adult disease or cancer, and it does not have known drug interactions, biomarker roles, or safety concerns relevant to pharmacology at this time. It is not conventionally considered a therapeutic target, but is of research interest for rare congenital diarrheal diseases[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline and glutamate rich with coiled coil domain protein 1 (PERCC1).